Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2017.6565
Abstract: Importance Prevalence of persistent central-involved diabetic macular edema (DME) through 24 weeks of anti–vascular endothelial growth factor therapy and its longer-term outcomes may be relevant to treatment. Objective To assess outcomes of DME persisting at… read more here.
Keywords: bevacizumab ranibizumab; bevacizumab; persistent dme; aflibercept bevacizumab ... See more keywords
PERMEABILITY AND ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR EFFECTS OF BEVACIZUMAB, RANIBIZUMAB, AND AFLIBERCEPT IN POLARIZED RETINAL PIGMENT EPITHELIAL LAYER IN VITRO
Sign Up to like & getrecommendations! Published in 2017 at "Retina"
DOI: 10.1097/iae.0000000000001117
Abstract: Purpose: To determine the effects of bevacizumab, ranibizumab, and aflibercept on the permeability and the effects of anti–vascular endothelial growth factor (VEGF) on highly polarized retinal pigment epithelial cells (RPECs) in vitro. Methods: Highly polarized… read more here.
Keywords: chamber; vegf; effects bevacizumab; layer ... See more keywords
Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Ophthalmology"
DOI: 10.1155/2020/9340356
Abstract: Purpose To study the short-term anatomical and functional outcomes in patients with neovascular age-related macular degeneration (nAMD) who were previously treated with conbercept and switched to ranibizumab or bevacizumab due to persistent activity. Methods This… read more here.
Keywords: bevacizumab; age related; related macular; bevacizumab ranibizumab ... See more keywords
Efficacy of Conversion to Aflibercept for Diabetic Macular Edema Previously Refractory to Bevacizumab or Ranibizumab: A Meta-analysis of High-Quality Nonrandomized Studies
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020904358
Abstract: Background: Aflibercept has been widely used in treating diabetic macular edema (DME). However, the effect of aflibercept in treating DME refractory to bevacizumab or ranibizumab has not been well established. Objective: To assess the therapeutic… read more here.
Keywords: refractory bevacizumab; bevacizumab; bevacizumab ranibizumab; diabetic macular ... See more keywords
Efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of macular edema secondary to central retinal vein occlusion.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2022.04.14
Abstract: AIM To explore the efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of central retinal vein occlusion (CRVO) through optical coherence tomography angiography (OCTA). METHODS Patients with prior treatment of a minimum of three… read more here.
Keywords: central retinal; switching bevacizumab; conbercept switching; efficacy conbercept ... See more keywords
Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept
Sign Up to like & getrecommendations! Published in 2017 at "Asia-Pacific Journal of Ophthalmology"
DOI: 10.22608/apo.2016186
Abstract: Purpose: To investigate the short‐term efficacy and safety of intravitreal aflibercept in a case series of patients with diabetic macular edema (DME) refractory to ranibizumab or bevacizumab. Design: A retrospective chart review. Methods: From September… read more here.
Keywords: bevacizumab; patients diabetic; bevacizumab ranibizumab; intravitreal aflibercept ... See more keywords